News

MassBio® Partners with Bayer to Launch Center for Regulatory Excellence to Support Startup Community March 9, 2020 in Announcements

MassBio® and Bayer today announced the Center for Regulatory Excellence, a first-of-its-kind forum for startups and academia to interact with and learn from regulatory experts. Read More

MassBio® Enters into Exclusive Partnership with Harvard Pilgrim Health Care to Offer Members Competitive Employee Benefits at a Lower Cost March 2, 2020 in Announcements

MassBio today announced that it has entered into an exclusive agreement with Harvard Pilgrim Health Care to offer member companies quality health plans through Edge Benefits. Read More

Eze Castle Integration Joins MassBio® Edge as a Preferred Partner February 28, 2020 in Announcements

MassBio today announced that Eze Castle Integration, the market leader in premier IT services, complete cloud solutions, and cybersecurity protections, has joined MassBio Edge as a Preferred Partner. Read More

Statement by MassBio President & CEO Robert K. Coughlin on the House Transportation Funding Bill February 27, 2020 in Policy Updates

“Transportation in Massachusetts is a growing economic development and talent recruitment and retention issue in the life sciences and beyond – one that MassBio is committed to helping address" Read More

MassBio® Announces Headliners for 2020 State of Possible Conference February 26, 2020 in Announcements

MassBio today announced the two keynote speakers for its annual State of Possible Conference taking place March 25-26, 2020 at the Royal Sonesta in Cambridge. Read More

MassBio® Welcomes Three Life Sciences Startups to Participate in 2020’s Inaugural MassCONNECT® Mentorship Cycle February 21, 2020 in Announcements

Last week, MassBio®’s MassCONNECT® launched its first mentorship cycle of 2020 with an opening showcase Read More

MassBio® Rare Disease Day to Recognize the Research Being Done in Massachusetts to Treat and Cure Rare Disease February 14, 2020 in Announcements

MassBio’s 2020 Rare Disease Day will call attention to the public health issues associate with rare diseases, which affect roughly 30 million Americans and countless others around the world. Read More

MassBio® Launches Mentoring Program for Digital Health Startups to Strengthen Digital Health Cluster in Massachusetts February 5, 2020 in Announcements

Last week, MassBio® launched a new mentoring program, MassCONNECT.DH, to support the growth and success of digital health startups in Massachusetts. Read More

Statement of Robert K. Coughlin President & CEO of MassBio on the Passage of H.R. 3 December 13, 2019 in Announcements

Members of the House who voted to pass H.R. 3 are now on record as supporting fewer new medicines coming to the market each year. Read More

Statement by MassBio President & CEO Robert K. Coughlin on the USMCA Compromise Bill December 12, 2019 in Policy Updates

The removal of enhanced IP protections for biologic medicines in the revised USMCA promises to jeopardize this ingenuity, opening the door for foreign free-riding on American medical innovation Read More